Daniel Swisher, President & CEO, Director at Viracta Therapeutics, holds 107.05K shares in Cerus (Ticker: CERS), holds 0.00 shares in Corcept Therapeutics (Ticker: CORT), holds 55.01K shares in Jazz Pharmaceuticals (Ticker: JAZZ). Most recently, Daniel Swisher Bought ― shares of Cerus on May 09, 2024 for an estimated value of 4.67K.